-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CT-38 in Lyme Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-38 in Lyme Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-38 in Lyme Disease Drug Details: CT-38 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-38 in Fibromyalgia (Fibromyalgia Syndrome)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CT-38 in Fibromyalgia (Fibromyalgia Syndrome) Drug Details:CT-38 is under development for the treatment of chronic fatigue...
-
Product Insights
Net Present Value Model: NeoRecormon/Epogin
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model NeoRecormon/Epogin Drug Details Epoetin Beta (Epoch,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CT-38
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CT-38 Drug Details CT-38 is under development for the treatment of chronic fatigue syndrome...